Royalty Pharma (RPRX) PT Raised to $59 at Goldman Sachs
Goldman Sachs analyst Asad Haider ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)